Advertisement

Responsive Advertisement
Asia-Pacific would exhibit the highest CAGR during the forecast period.
Snapshot of Asia-Pacific intelligent asthma monitoring devices market
Saudi Arabia is expected grow at the highest CAGR of 9.8%, owing to the presence of ample growth opportunities in terms of unmet medical needs and increasing healthcare investments
Global powered surgical instrument market is expected to exhibit significant growth during the forecast period
The hospital segment is projected to grow at the highest CAGR of 5.9% during the forecast period
Azoles projected to be the primary drug type in the near future
The private cord blood bank segment is expected to register the highest growth rate during the forecast period
Rise in demand for vaccine, owing to growth in number of geriatric population further fuels the market growth.
U.S. was the major shareholder in the North American immunoprotein diagnostic testing market, accounting for 87.23% share
Metabolomics in precision medicine are expected to boost the North America metabolomics market.
The emerging trends in protein labeling such as emergence of more specific labels with higher affinity and binding properties, bioorthogonal labelin